Speech Entrainment Treatment for People With Aphasia

Description

The objective of this research is to experimentally delineate the direct effect of speech entrainment practice on independent speech production and identify practice conditions that enhance treatment benefits. The primary outcome measure (Correct Information Units per minute) tallies informativeness and efficiency of independent speech in treated stories.

Conditions

Aphasia, Acquired

Talk to us

Study Overview

On this page

Study Details

Study overview

The objective of this research is to experimentally delineate the direct effect of speech entrainment practice on independent speech production and identify practice conditions that enhance treatment benefits. The primary outcome measure (Correct Information Units per minute) tallies informativeness and efficiency of independent speech in treated stories.

Efficacy and Optimization of Speech Entrainment Practice for People With Aphasia

Speech Entrainment Treatment for People With Aphasia

Condition
Aphasia, Acquired
Intervention / Treatment

-

Contacts and Locations

Elkins Park

Moss Rehabilitation Research Institute, Elkins Park, Pennsylvania, United States, 19027

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Between 18-80 years at the time of enrollment
  • * English as native language
  • * greater than six months post onset
  • * Diagnosis of aphasia based on Western Aphasia Battery - Revised (WAB-R)
  • * Score of 7 or less on the Fluency subsection of the WAB-R
  • * Demonstrate having the willingness and stamina to participate in the multiple-session protocol, either by traveling to the MRRI testing site or being tested at home
  • * History of learning disabilities
  • * History of other comorbid neurological impairments

Ages Eligible for Study

18 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Albert Einstein Healthcare Network,

Marja-Liisa Mailend, PhD, PRINCIPAL_INVESTIGATOR, Albert Einstein Healthcare Network

Study Record Dates

2025-07